Ascentcare Dental Products, Inc. v. Solmetex, LLC

IPR2025-01057

Ascentcare Dental Products has petitioned the PTAB to invalidate Solmetex’s 12,290,418 intraoral device patent, alleging obviousness over six prior‑art references. The petition seeks cancellation of 25 claims covering the isolation mouthpiece.

Jurisdiction
US PTAB
Case Number
IPR2025-01057
Filing Date
28 May 2025
Status
ok

Related Cases

patentIPR2024-01046

Sony CorporationvsOptimum Imaging Technologies LLC

Sony and Optimum Imaging Technologies have settled their dispute over U.S. Patent 10,877,266. The parties filed a joint motion to terminate the inter partes review, citing 35 U.S.C. § 317. The Board is asked to dismiss the proceeding.

patentIPR2025-00718

PacifiCorp et al.vsMES, Inc.

PacifiCorp challenges the patent owner’s request for Director Review of IPR2025‑00718, arguing procedural errors, misstatements in prosecution, and that the PTAB is the proper forum. The petition seeks denial of the Director’s discretionary denial under §315(d).

patentPGR2025-00064

SAMSUNG ELECTRONICS CO., LTD. et al.vsOMNI MEDSCI, INC.

Samsung (on behalf of Apple) petitions the PTAB to invalidate Omni MedSci’s ’533 wearable health‑monitoring patent. The petition asserts that the claims are obvious over Lisogurski, Carlson, and Mannheimer references. No secondary considerations are presented.

patentIPR2024-00787

Hulu LLC et al.vs--

Hulu and Capital One filed an unopposed motion to keep their settlement agreement with Implicit confidential and to terminate the IPR. The Board is asked to treat the agreement as business confidential information under 35 U.S.C. §317(b).

patentIPR2024-01119

Apple Inc.vsSmith Interface Technologies, LLC

The PTAB granted institution for Apple Inc.'s IPR against Smith Interface Technologies, LLC regarding gesture recognition technology. The Board found a reasonable likelihood of prevailing on obviousness grounds over Ahn and Chaudhri for Claim 2.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call